Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress

J Culman, S Klee, C Ohlendorf, T Unger - Journal of Pharmacology and …, 1997 - ASPET
The neurokinins, substance P (SP) and neurokinin A (NKA) represent natural, nonspecific
ligands of NK1 and NK2receptors. In our study in conscious rats, we tested the hypothesis …
被引用次数：99 相关文章
[PDF] psu.edu

[PDF][PDF] Effect of Tachykinin Receptor Inhibition in the Brain on Cardiovascular and Behavioral Responses to Stress

J CULMAN, S KLEE, C OHLENDORF… - THE JOURNAL OF …, 1997 - Citeseer
The neurokinins, substance P (SP) and neurokinin A (NKA) represent natural, nonspecific
ligands of NK1 and NK2 receptors. In our study in conscious rats, we tested the hypothesis …

Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress

J Culman, S Klee, C Ohlendorf, T Unger - Journal of Pharmacology …, 1997 - hero.epa.gov
The neurokinins, substance P (SP) and neurokinin A (NKA) represent natural, nonspecific
ligands of NK1 and NK2 receptors. In our study in conscious rats, we tested the hypothesis …

Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress

J Culman, S Klee, C Ohlendorf… - The Journal of …, 1997 - pubmed.ncbi.nlm.nih.gov
The neurokinins, substance P (SP) and neurokinin A (NKA) represent natural, nonspecific
ligands of NK1 and NK2 receptors. In our study in conscious rats, we tested the hypothesis …

Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.

J Culman, S Klee, C Ohlendorf… - The Journal of …, 1997 - europepmc.org
The neurokinins, substance P (SP) and neurokinin A (NKA) represent natural, nonspecific
ligands of NK1 and NK2 receptors. In our study in conscious rats, we tested the hypothesis …

[引用][C] EFFECT OF TACHYKININ RECEPTOR INHIBITION IN THE BRAIN ON CARDIOVASCULAR AND BEHAVIORAL RESPONSES TO STRESS

J CULMAN, S KLEE… - The Journal of …, 1997 - American Society for Pharmacology …